GL1X · GenesisL1 explorer

MolNFT v1 · #20424 · protein

Endo-1,4-beta-xylanase II complex with 4,5-epoxypentyl-beta-D-xyloside

1RED: “Endo-1,4-beta-xylanase II complex with 4,5-epoxypentyl-beta-D-xyloside”. X-ray diffraction, 2 ligands (C5X, BEZ), 3 pockets (best druggability 0.52). MolNFT v1 #20424 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
1RED
Type
protein
Length
380 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Endo-1,4-beta-xylanase II
EC
3.2.1.8
UniProt
P36217
Ligands
C5X, BEZ
Pockets
3 · best druggability 0.52

Structure

x-ray diffraction · 1 distinct chain · 5% helix, 62% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BEndo-1,4-beta-xylanase II (EC 3.2.1.8)protein1905% helix, 62% strandP36217

Ligands and binding sites

  • C5X · 3-[(2R)-oxiran-2-yl]propyl beta-D-xylopyranoside · ligand · chains B
  • BEZ · Benzoic acid · ligand · chains B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12050.520.7733C5X
22640.490.7344empty
3970.380.7627empty

Interfaces

1 interface between chains.

  • A–B · 185 Ų buried · 2 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 2 modified, 1 covalent (cyclization, covalent ligand).

Compared structures

  • 1RED · Endo-1,4-beta-xylanase II complex with 4,5-epoxypentyl-beta-D-xyloside · the same entry in another collection · chain A against A, TM-score 1.00
  • P36217 · AlphaFold monomer V2.0 prediction for endo-1,4-beta-xylanase 2 (P36217) · a predicted model of the same protein · chain A against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.